Your browser doesn't support javascript.
loading
Dulaglutide and insulin microsecretion in people with type 1 diabetes (DIAMOND-GLP-1): A randomized double-blind placebo-controlled trial.
Thivolet, Charles; Larger, Etienne; Cariou, Bertrand; Renard, Eric; Hanaire, Hélène; Benhamou, Pierre-Yves; Guerci, Bruno; Mathiotte, Émilie; Chikh, Karim.
Afiliação
  • Thivolet C; Centre du diabète DIAB-eCARE, Hospices Civils de Lyon, Université Claude Bernard Lyon 1, Lyon France. Electronic address: charles.thivolet@chu-lyon.fr.
  • Larger E; Department of Diabetology, Cochin Hospital AP-HP, University of Paris, Paris, France.
  • Cariou B; Nantes Université, CHU Nantes, CNRS, INSERM, l'institut du thorax, Nantes F-44000, France.
  • Renard E; Department of Endocrinology, Diabetes and Nutrition, Montpellier University Hospital, University of Montpellier, Montpellier, France.
  • Hanaire H; Department of Diabetology, Metabolic diseases and Nutrition, CHU Toulouse, University of Toulouse, Toulouse, France.
  • Benhamou PY; Department of Endocrinology, Grenoble University Hospital, Grenoble Alpes University, INSERM U1055, LBFA, Grenoble, France.
  • Guerci B; Department of Endocrinology, Diabetology and Nutrition, CHRU of Nancy, Brabois Hospital, and ILCV Lorraine University, Vandoeuvre-les-Nancy, France.
  • Mathiotte É; Department of Clinical Research, pole IMER Hospices Civils de Lyon, Lyon, France.
  • Chikh K; Department of biochemistry and molecular biology, Lyon-Sud Hospital, Hospices Civils de Lyon, Lyon, France, Université Claude-Bernard Lyon 1, Oullins, France.
Diabetes Metab ; 49(2): 101433, 2023 03.
Article em En | MEDLINE | ID: mdl-36781064

Texto completo: 1 Coleções: 01-internacional Contexto em Saúde: 1_ASSA2030 / 2_ODS3 Base de dados: MEDLINE Assunto principal: Diabetes Mellitus Tipo 1 / Peptídeo 1 Semelhante ao Glucagon Tipo de estudo: Clinical_trials Limite: Humans Idioma: En Revista: Diabetes Metab Ano de publicação: 2023 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Contexto em Saúde: 1_ASSA2030 / 2_ODS3 Base de dados: MEDLINE Assunto principal: Diabetes Mellitus Tipo 1 / Peptídeo 1 Semelhante ao Glucagon Tipo de estudo: Clinical_trials Limite: Humans Idioma: En Revista: Diabetes Metab Ano de publicação: 2023 Tipo de documento: Article